In a move that makes way for Eisai Pharmaceuticals, Prism Capital Partners announced it will be relocating its headquarters to 310 Kingsland St. at ON3.
ON3 is Prism’s 116-acre flagship redevelopment, which spans Nutley and Clifton.
Prism’s move from 200 Metro Blvd., where the firm has operated since 2019, makes way for Eisai, a pharmaceutical company that signed a full-building commitment for the 15-story LEED Gold tower last summer.
“Our move reflects Prism’s flexibility and our support of the progress and growth of ON3,” Prism Principal Partner Edwin Cohen said. “We are committed to keeping our unified operations here and remaining part of everyday life within this vibrant, evolving community.”
Prism’s new home at 310 Kingland St., a former conference center building, has been built out by the firm’s in-house construction team.
Cohen said the long-term plan is to design and develop a stand-alone Prism headquarters building on the ON3 campus.
Eisai Inc.’s lease of 200 Metro Blvd. marked New Jersey’s largest office lease in 2020. The blockbuster transaction — made even more impressive via its execution during a global pandemic — brought ON3’s 1.45 million square feet of existing office and R&D/lab product to 100% occupancy.
Eisai will relocate its New Jersey-based headquarters from Woodcliff Lake to ON3, with plans to transfer up to 1,200 of its corporate staff and research & development team by late 2021.
